Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001274173-25-000254·Janus Henderson Group Ltd.
Schedule 13G ownership disclosure
Vistagen Therapeutics Inc
Common Stock · CUSIP: 92840H400
Event date: 2025-08-29
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- JANUS HENDERSON GROUP PLC
Shares: 4,165,767 · Class: 13.6%
- Janus Henderson Biotech Innovation Master Fund Ltd
Shares: 3,575,276 · Class: 11.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-25-000254
- Form type
- SCHEDULE 13G
- Filer
- Janus Henderson Group Ltd.
- CIK
- CIK 1274173
- Filed
- Sep 08, 2025
- Reporting period
- Aug 29, 2025
- Description
- Schedule 13G beneficial ownership